The headquarters of the Vigo Free Trade Zone Consortium hosts the main life sciences investment forum in Galicia, organized by Bioga, the Vigo Free Trade Zone and EDIH DATAlife
Vigo. October 30th 2025. Nine Galician biotech startups and initiatives are being presented today to representatives of 22 investment entities, funds and institutional investors at BioInvestor Days, the main investment forum in life sciences in Galicia, organized by the Business Technology Cluster of Life Sciences (Bioga) and the Vigo Free Zone Consortium with the collaboration of EDIH DATAlife (European Digital Innovation Hub of Galicia), and which has taken place on October 29 and 30, 2025 at the headquarters of the Vigo Free Zone Consortium.
The nine selected companies and initiatives, which have high growth potential and are seeking funding to launch or boost their projects, are requesting financing ranging from €50,000 to €2.5 million. The combined funding needs of the nine companies total approximately €7 million.
The BioInvestor Days are a meeting point for startups and a network of specialized investors, funds, corporations, and financial institutions. During the event, presentations, B2B meetings, talks, and roundtables are being held to generate collaboration and investment opportunities. This forum is the culmination of the BioInvestor Program, a prior training program for entrepreneurial projects in the sector, and is part of the IberoBio project, co-financed by the European Regional Development Fund (ERDF) under the Interreg VI Spain-Portugal program (POCTEP) 2021-2027.
The event began on Wednesday, October 29, with an official welcome address by the President of Bioga, José Manuel López Vilariño; Patricia Fraga, Coordinator of the Health, Care, and Biotechnology Area at EDIH DATAlife; and David Regades, Special State Delegate to the Vigo Free Trade Zone. This was followed by individual presentations and roundtables designed to facilitate networking among investment funds, organizations, and projects.
Today, Thursday, October 30, 2025, the projects selected for the 11th BioInvestor Program will be presented to a network of specialized investors (venture capital firms, business angels, family offices, corporations, and financial institutions). Networking activities, B2B meetings, and connection sessions between ecosystem stakeholders are also planned.
Investing in talent
The Special State Delegate to the Vigo Free Trade Zone, David Regades, highlighted “the Consortium’s strong support for this sector, which offers innovative solutions for health, food, and the environment, among other areas, contributing to sustainable economic growth and strategic autonomy. These are the reasons why the Free Trade Zone is actively participating for the third time in an Interreg project, collaborating with Bioga and other stakeholders to strengthen the biotechnology sector.” For his part, José Manuel López Vilariño, president of Bioga, explained that “from the heart of the biotechnology ecosystem, we aim to promote and boost productive investment in our sector in Galicia. For over a decade, we have been working to ensure that value-added projects based on research and talent have the opportunity to present themselves to leading investors in the life sciences.”
The companies that presented their projects at the 11th BioInvestor Day are:
AlpineFlame addresses the impact of cold weather on outdoor sports activities. The company has identified various natural supplements that improve cold resistance and delay hypothermia in preclinical in vivo models. It is seeking an investment of €50,000 to develop a Minimum Viable Product to validate market interest and solidify the scientific evidence.
ANABONIC develops innovative biotechnology therapy based on the secretome of human osteogenic cells with bone anabolic and anti-adipogenic properties. The company proposes a first-in-class therapy based on the patented secretome of genetically heterotopic ossification cells that promotes sustained bone neoformation and inhibits bone adipogenesis. It is seeking €2.5 million for preclinical development and regulatory approval.
BioSmartData is a cloud platform that captures and structures real-world clinical data, transforming it, through AI, into predictive models that anticipate responses, optimize treatments, and measure therapeutic efficiency. It’s seeking funding for a model to transition “from a clinical tool to an evidence-based infrastructure for the healthcare ecosystem.” Capital sought: €1 million.
HEMO-IMPROVE is a healthcare software platform that combines advanced image analysis and artificial intelligence to evaluate arterial calcium in contrast-enhanced CT scans. Its goal: to improve decision-making in interventional cardiology, reducing risks such as stroke or vascular complications. Capital sought: €700,000.
Kiur is a clinical decision support software that allows any healthcare professional to select the optimal products for treating any curable chronic wound. Thanks to AI integrated into an intuitive and robust application, treatment variability is reduced, healing is accelerated, and costs are lowered. Capital sought: 1 million.
Orixe Salgada is a pioneering initiative in Galicia focused on the development of a biorefinery for the processing of seaweed from beaching using 100 percent natural techniques.
REMOVIRT is software that enables the automatic 3D virtual reconstruction and modeling of the liver using Artificial Intelligence. Its business model focuses on selling this technology and related products to intermediary technology companies. Capital sought: €700,000
Science & Business is a project that develops and markets a kit for detecting pathogenic bacteria, including variants and antibiotic resistance, for diagnostic use in the veterinary and human sectors. Capital sought: €1 million.
Aguas de Rodas is a spinoff focused on developing innovative solutions based on aquatic resources for health and well-being. The project successfully completed all research and has a validated product, ready for industrial scaling and commercialization.
+ info: Bioga Press: 679.486.961.
